ABSTRACT. Familial isolated growth hormone deficiency type IA results from homozygosity for either a 6.7-kb or a 7.6-kb hGH-1 gene deletion. Genomic DNA was extracted from circulating lymphocytes of 78 subjects with severe isolated growth hormone deficiency (height < -4.5 S D score) and studied by polymerase chain amplification and by restriction endonuclease analysis looking for gene deletions within the hGH-gene cluster. The individuals analyzed were broadly grouped into three different populations (North-European, n = 32; Mediterranean, n = 22; and Turkish, n = 24). Ten out of 78 patients studied presented with an hGH-1 gene deletion; eight out of these 10 showed a 6.7-kb gene deletion, the remaining two a 7.6-kb hGH-1 gene deletion. Five of the 10 subjects developed anti-hGH antibodies to hGH replacement followed by a stunted growth response. Family studies of the affected patients were performed, revealing consanguinity in all the families, and the corresponding heterozygosity for the deletion was present in each of the parents. The results of our study revealed a prevalence for an hGH-1 gene deletion in three out of 32 North-European, three out of 22 Mediterranean, and four out of 24 Turkish patients with growth hormone deficiency (height < 4.5 SD score). These data are important for prenatal diagnosis of at-risk pregnancies and for families at risk for recurrence and underline clearly the fact that the hGH
ABSTRACT. Familial isolated growth hormone deficiency type IA results from homozygosity for either a 6.7-kb or a 7.6-kb hGH-1 gene deletion. Genomic DNA was extracted from circulating lymphocytes of 78 subjects with severe isolated growth hormone deficiency (height < -4.5 S D score) and studied by polymerase chain amplification and by restriction endonuclease analysis looking for gene deletions within the hGH-gene cluster. The individuals analyzed were broadly grouped into three different populations (North-European, n = 32; Mediterranean, n = 22; and Turkish, n = 24). Ten out of 78 patients studied presented with an hGH-1 gene deletion; eight out of these 10 showed a 6.7-kb gene deletion, the remaining two a 7.6-kb hGH-1 gene deletion. Five of the 10 subjects developed anti-hGH antibodies to hGH replacement followed by a stunted growth response. Family studies of the affected patients were performed, revealing consanguinity in all the families, and the corresponding heterozygosity for the deletion was present in each of the parents. The results of our study revealed a prevalence for an hGH-1 gene deletion in three out of 32 North-European, three out of 22 Mediterranean, and four out of 24 Turkish patients with growth hormone deficiency (height < 4.5 SD score). These data are important for prenatal diagnosis of at-risk pregnancies and for families at risk for recurrence and underline clearly the fact that the hGH-I gene deletion represents a common cause for growth hormone deficiency associated with severe growth retardation (height < -4.5 SD score). (Pediatr Res 31: 532-534,1992) Abbreviations IGHD, isolated growth hormone deficiency PCR, polymerase chain reaction GH, growth hormone hCS, human chorionic somatomammotropin gene Short stature associated with abnormalities of GH secretion results from a variety of genetic and acquired interruptions in the hypothalamo-pituitary-peripheral axis. In the United Kingdom, the prevalence of GH deficiency is reported to be between 1 in 4000 and 1 in 10 000 (1). Five to 30% of GH-deficient patients have a GH-deficient relative; therefore, the disorder is suggested to be familial (2) . Four distinct familial types of IGHD are well-differentiated on the basis of inheritance and other hormone deficiencies (3). One form is IGHD type IA, resulting from a GH-1 gene deletion (4, 5) . Subjects with IGHD type IA may have short body length at birth and present occasionally with hypoglycemia, but severe growth retardation by 6 mo of age is a constant finding. Treatment with hGH is frequently complicated by the development of anti-hGH antibodies in a titer sufficient to cause arrest ofresponse to the hGH replacement (6) . However, an increasing number of patients have been reported in whom immune intolerance after GH treatment has not developed (7, 8) . This has led to the idea that IGHD type IA cannot be identified on the basis of anti-hGH antibodies causing growth arrest. A second autosomal recessive type of IGHD (type IB) is characterized by the production of insufficient amounts of hGH after provocative stimuli; in contrast to IGHD type IA, no detectable hGH gene deletions are described (3) . A third form (IGHD type 11) has an autosomal dominant mode of inheritance, whereas a fourth one (IGHD type 111) is X-linked inherited (3). The same criteria used to diagnose IGHD type IB apply to IGHD type I1 and type 111.
Using Southern blot analysis, we found neither homozygous nor heterozygous patterns of hybridization for hGH-I gene deletions among 53 British children with milder forms of IGHD and concluded that structural abnormalities of the hGH gene cluster detectable by endonuclease analysis are an uncommon cause of GH deficiency (9) . Recently, a rapid method using PCR amplification has been developed to facilitate detection of hGH-1 gene deletions (10) . To determine the prevalence of hGH-1 gene deletions in different populations (North-European, Mediterranean, and Turkish) and to challenge the generally held assumption that the hGH-1 gene deletion is uncommon in IGHD, we analyzed patients with severe forms of IGHD (height < -4.5 SD score) using the PCR amplification method and Southern blotting.
MATERIALS AND METHODS

Patients.
The individuals studied were broadly grouped into three populations, North-European, Mediterranean, and Turkish. The North-European population included individuals from the northern part of the Alps, and the Mediterranean group comprised Italians, Spaniards, and Greeks who were either living in Switzerland or who were referred to our outpatient clinic from abroad because of short stature. The Turkish population living in the area of Ankara composed the third group. Seventy-eight PREVALENCE OF hGH-I GENE DELETIONS 533 stimulation test (insulin-induced hypoglycemia). Details of the fusion fragments of 1918 bp composed of portions from both patients are shown in Table 1. homologous regions. After digestion with SmaI, the 1918-bp The families of the patients with either a 6.7-or a 7.6-kb fusion fragments derived from homozygotes for the 6.7-kb gene hGH-1 gene deletion were also studied to analyze the parental deletion yielded fragments of 1470 and 448 bp. Therefore, the heterozygosity for the disorder.
pattern of DNA fragments after SmaI digestion of the PCR Methods. DNA isolation. Genomic DNA was isolated from amplification products in patients homozygous for 6.7-kb deleperipheral leukocytes of subjects and relatives as previously tions involving the hGH-1 gene are 1470 and 448 bp in length described (9, 11) . The concentration of each sample was deter- (Fig. la) .
mined by measuring the OD of the purified DNA at 260 and Unequal recombination between two 29-bp perfect repeats is 280 nm.
believed to give rise to the 7.6-kb gene deletions (5), and, after Restricfion endonuclease digestion and Southern blot analysis. PCR amplification, the 1900-bp PCR product is retained whereas Samples of DNA (5 rg) were digested to completion with the the 192 1-bp product is lost as a result of the 7.6-kb deletion of restriction enzymes BamHI and HindIII. After electrophoresis the genomic DNA. In these cases, because the 1900-bp fragment in 0.5-1.2% (wt/vol) agarose gels, the DNA fragments were has no SmaI restriction site, the highly homologous block 5' to transferred onto nylon membranes (Hybond-N; Amersham In-the hGH-I gene is retained after SmaI digestion, yieldinga 1900-ternational, Little Chalfont, Buckinghamshire, UK) and hybrid-bp fragment (Fig. 16) . ized to the hGH probe as previously described (9, 1 I). The filters In 12.8% of the patients analyzed, an hGH-1 gene deletion were then washed at 65'C and autoradiographed at -70°C using could be found. Eight individuals were homozygous for a 6.7-kb intensifying screens (9, I 1).
gene deletion, whereas only two patients, previously described DNA amplification. The hGH-1 gene encodes the hGH peptide by Braga et al. (8) , were homozygous for a 7.6-kb deletion of (12) . Deletions of this locus can be detected by Southern blot genomic DNA ( Table 2 ). There was a pair of affected brothers analysis after HindIII or BamHI digestion and hybridization to with the 6.7-kb gene deletion among the North-European popthe hGH-1 cDNA probe. Eighty percent of the hGH-1 gene ulation, a pair of sisters with the 7.6-kb gene deletion among the deletions characterized are 6.7 kb in length, and the remaining Mediterranean population (8) , and two pairs of affected brothers cases mainly involve 7.6-kb deletions (3, 5) . Because there is with the 6.7-kb gene deletion among the Turkish population extensive homology between regions in the 5' and 3' flanking ( Table 2) . region of the hGH-1 gene (5, 12), unequal recombination beSouthern blot analysis. The size of the deletion was analyzed tween these two highly homologous regions is the main cause for by performing Southern blotting. 6.7-kb deletions of genomic DNA encompassing the hGH-1 gene In 10 out of the 78 patients, the 3.8-kb BarnHI band was (5). DNA amplification of these highly homologous regions was missing, supporting the existence of an hGH-1 gene deletion. performed using PCR, as described by Vnencak-Jones el al. (10) . Inasmuch as both hGH-1 and hCS-L reside in a 25-kb HindIIIThe PCR analysis has been done with oligonucleotide primers derived fragment, the size of the majority of the deletions (6.7 that anneal to the 5' and 3' ends of these homologous regions and 7.6 kb) can be determined after HindIII digestion of the (10) . After amplification, 25 r L of each reaction mixture were DNA (4). The data obtained by Southern blotting were identical digested with the restriction endonucleases SmaI, BgfI, and to the PCR data. HaeII. Because differences in restriction endonuclease sites exist,
In three out of the 10 patients (all 6.7-kb deletions), the hGH the analysis of the fragment pattern after enzyme digestion allows replacement was stopped after 6-12 mo because the anti-hGH the definition of the hGH-1 gene deletion. The digested PCR antibodies produced caused growth arrest, whereas in patients products were visualized after electrophoresis on a 0.8% agarose (two) with 7.6-kb deletions the anti-hGH antibody production gel.
did not blunt the growth effect of hGH treatment. Family studies. The 78 individuals studied belonged to 15 RESULTS North-European, eight Mediterranean, and eight Turkish families. The families were unrelated, and each had one or more PCR ampliJication analysis. PCR amplification of the homol-individuals with IGHD. The family members of the affected o p u s regions flanking the hGH-1 gene produced two DNA children were analyzed for heterozygosities of the reported fragments (1900 and 192 1 bp) from genomic control DNA. After hGH-1 gene deletion using Southern blotting and the PCR digestion of these PCR amplification products with SmaI, the amplification method. In each parent of normal stature, the 1900-bp fragment, deriving from the amplification of the first corresponding heterozygous pattern for the hGH-1 gene deletion highly homologous block 5' to the hGH-I gene, was not cleaved, could be found. Most interestingly, there was a history of conwhereas the 192 1-bp amplification product from the homologous sanguinity in all of the families with an affected child, whereas a block 3' to the hGH-1 gene yielded fragments of 761, 7 12, and history of consanguinity was found in none, one, and two of the 448 bp. The pattern of DNA fragments obtained by SmaI remaining North-European, Mediterranean, and Turkish famidigestion of PCR amplification products in the control patient is lies without hGH-I gene deletions, respectively. The different shown in Figure 1 . degree of consanguinity in the three subpopulations selected may Unequal recombinational events between these highly homol-be the cause of the higher prevalence of hGH-1 gene deletions ogous regions 5' and 3' to the hGH-I gene produce 6.7-kb in the Turkish and Mediterranean subpopulations compared deletions of genomic DNA containing the hGH-1 gene and with the North-European subpopulation with severe IGHD. 5 34
M U L L I S ET AL. Open circles represent subjects without a deletion; hafched circles represent subjects heterozygous for hGH-1 gene deletions, a n d filled circles represent subjects homozygous for hGH-I gene deletions. a , T h e 6.7-kb hGH-1 gene, deletion; b, the 7.6-kb hGH-1 gene deletion. Parks et al. ( 13) reported that 38% (five out of 13) of Oriental Jewish patients with severe (height < -4 SD score) IGHD had an hGH-I gene deletion. None of these children produced a titer of anti-hGH antibodies sufficient to cause growth arrest (13) . Studies among Chinese and Japanese subjects found a prevalence of hGH-1 gene deletions of 12% (three out of 26) and 0% (zero out of lo), respectively (10, 14) .
The results of our study analyzing a total of 78 patients revealed a prevalence for hGH-1 gene deletion of 9.4, 13.6, and 16.6% in the subpopulation ofchildren with severe IGHD (height c -4.5 SD score) of North-European, Mediterranean, and Turkish descent, respectively.
In 80% (eight out of lo), the hGH-1 gene deletion found was spanning 6.7 kb, which is in accordance with the figure reported by Phillips et al. (4) . In addition, the affected subjects could not be distinguished from the children without gene deletion based on clinical findings. Notably, children without an hGH-1 gene deletion and those with a deletion of genomic DNA encompassing the hGH-1 gene can have equally severe growth retardation.
Compared with the PCR technique, Southern blotting is slow, time consuming, and laborious. Therefore, the PCR amplification method provides a real alternative to Southern blotting for identification and screening for homozygotes for hGH-1 gene deletions.
It is of interest that the two patients with a 7.6-kb deletion did not show any growth arrest, even though they developed a level of anti-hGH antibodies (68% maximum binding of 1251-hGH) similar to that of two patients with a 6.7-kb deletion (64% and 66% maximum binding of "'1-hGH) in whom the hGH treatment became blunted.
This study revealed, in contrast to our previous data, a high prevalence of hGH-I gene deletions in the subpopulation of children with severe IGHD (height < -4.5 SD score), selected from three apparently highly inbred populations of NorthEuropean, Mediterranean, and Turkish descent. In addition, the fact that all the families with hGH-1 gene deletions were consanguineous is of interest for the prenatal diagnosis of at-risk pregnancies and for families at risk for recurrence.
